Erenumab efficacy in chronic migraine and medication overuse: a real-life multicentric Italian observational study
Neurol Sci
.
2020 Dec;41(Suppl 2):489-490.
doi: 10.1007/s10072-020-04670-5.
Authors
Francesca Schiano di Cola
1
,
Renata Rao
2
,
Salvatore Caratozzolo
2
,
Marco Di Cesare
2
,
Elisabetta Venturelli
3
,
Ubaldo Balducci
4
,
Vincenzo Sidoti
4
,
Elisa Pari
5
,
Chiara Costanzi
5
,
Alfonsina di Summa
6
,
Gabriele Johanna Sixt
6
,
Elisabetta D'Adda
7
,
Paolo Liberini
2
,
Alessandro Padovani
2
Affiliations
1
Neurology Unit, University and Spedali Civili Clinical and Experimental Sciences Department, Piazzale Spedali Civili 1, 25123, Brescia, Italy.
[email protected]
.
2
Neurology Unit, University and Spedali Civili Clinical and Experimental Sciences Department, Piazzale Spedali Civili 1, 25123, Brescia, Italy.
3
Neurology Unit, ASST Papa Giovanni XXIII, Bergamo, Italy.
4
Neurology Unit, P.O. Chiari, ASST Franciacorta, Franciacorta, Italy.
5
Neurology Unit, Ospedale di Cremona, ASST Cremona, Cremona, Italy.
6
Neurology Unit, Ospedale Centrale di Bolzano, Azienda Sanitaria dell'Alto Adige, Bolzano, Italy.
7
Neurology Unit, Ospedale Maggiore di Crema, ASST Crema, Crema, Italy.
PMID:
32856234
DOI:
10.1007/s10072-020-04670-5
No abstract available
Publication types
Observational Study
MeSH terms
Antibodies, Monoclonal, Humanized / therapeutic use
Chronic Disease
Humans
Italy
Migraine Disorders* / drug therapy
Prescription Drug Overuse*
Substances
Antibodies, Monoclonal, Humanized
erenumab